INTRODUCTION
Central venous catheters are now used widely in the care of critically ill patients; they deliver total parenteral nutrition and drug therapy, and facilitate hemodynamic monitoring. However, these catheters can cause central venous thrombosis. 1e9 Moreover, the long-term hospitalized critically ill patients who receive central venous catheters have a higher risk of malnutrition, which is associated with immunosuppression, which, in turn, is a risk factor for infection. 6e11 However, the incidence of central venous catheter related infected thrombosis (which affects the internal jugular or subclavian veins and vena cavae) is small. Indeed, suppurative deep venous thrombosis in critically ill patients is sometimes detected only incidentally during diagnostic work up. Conservative management consisting of removing the catheter, antibiotic therapy, and anticoagulation therapy can resolve this condition in the majority of patients. However, occasionally it fails and serious complications, such as persistent bacteremia, shock, and metastatic infection can occur. 3e9 If conservative management fails, the best treatment for symptomatic catheter related thrombosis is unclear. Although some authors believe that a surgical approach that aims to remove the infected clots is a last treatment modality for critically ill patients with septic thrombosis that is refractory to conservative management, others consider venous thrombectomy to be unnecessary. 1e9 This study was designed to explore two aspects of catheter related infected central venous thrombosis. First, the clinical features and outcomes of catheter related central venous thrombosis were assessed. Second, whether a surgical approach can be an effective treatment modality in selected cases that are refractory to conservative management was also investigated.
METHODS
This retrospective observational study was based on data that were extracted from patient medical records. The study protocol was approved by the hospital institutional review board. The study population consisted of 50 consecutive patients who were suspected of central venous catheter related septic deep venous thrombosis and who received conservative management at a tertiary care institution (Asan Medical Center) between January 2009 and December 2012 ( Fig. 1) . The inclusion criteria for the present study were as follows: (1) temperature ! 38.4 C, which persisted for > 2 days after the removal or change of the central venous catheter and antibiotic therapy; (2) a central venous catheter was in place prior to and up to the onset of fever; (3) Duplex ultrasonography (DUS) or computed tomographic (CT) scanning revealed the presence of central venous catheter related thrombosis; and (4) there were no other plausible causes of fever or sepsis. Clinical improvement was defined as the continuous abatement of fever without any evidence of sepsis and negative culture results despite discontinuation of antimicrobial therapy.
At the authors' institution, conservative management is the first therapy of choice. When central venous catheter related thrombosis is suspected to be the source of sepsis, the line is either removed directly or changed over a guidewire. A 3 inch segment of catheter just distal to the hub is then sent for culture, and blood for blood culture is obtained via the catheter. After appropriate blood and catheter sample culture, empirical intravenous antimicrobial therapy and anticoagulation therapy are initiated on the basis of clinical clues, the severity of the patient's illness, the underlying disease, and the potential pathogens.
All surgical procedures in the study population were for internal jugular vein thrombosis. Surgical procedures were performed under general anesthesia. The patient was placed in the supine position and the head was slightly extended and turned away from the side of the operation. A vertical skin incision was made along the palpable anterior border of the sternocleidomastoid muscle. After adequate dissection, the internal jugular vein was exposed. The regions that were proximal and distal to the thrombosed vein appeared to be free of disease and vein cross clamping was performed after systemic heparinization. A longitudinal venotomy was made: it extended beyond the proximal and distal end points of the thrombosed vein segment if possible, and open thrombectomy was performed. Primary closure was performed with optical 3.5 Â power magnification and Prolene 6/0 continuous sutures. All patients were anticoagulated and were followed up both clinically and by DUS or CT scanning. Anticoagulant therapy was delivered as a regimen of low molecular weight heparin at a therapeutic dose, except in six patients who received conventional heparin because of poor renal function.
The risk factors of interest and other data, including clinical presentation, management details, and clinical outcomes, were recorded prospectively in an Excel spreadsheet (Microsoft, Redmond, WA, USA) and were analyzed retrospectively. Categorical data are reported as counts and percentages, while continuous data are reported as means AE SD.
RESULTS

Patient population
Between January 2009 and December 2012, 50 consecutive patients were suspected of having central venous catheter related infected thrombosis. However, four patients failed the eligibility criteria because they had other causes of fever or sepsis ( Fig. 1 ). All were excluded, leaving 46 patients. All patients received conservative management. The demographics and clinical characteristics of these patients are shown in Table 1 . The most common underlying disease was malignancy (n ¼ 23; 50.0%), and 24 (52.2%) patients were in an intensive care unit at the onset of the syndrome. The reasons for central venous catheter placement, the diagnostic modality used to detect thrombosis, and the location of thrombus are summarized in Table 1 . The mean duration of central venous catheterization was 23.7 AE 19.2 days, and the mean duration from the placement of the central venous catheter to the diagnosis of catheter related thrombosis was 25.5 AE 15.4 days. The mean length of stay in an intensive care unit was 35.6 AE 45.6 days, and the average overall length of hospital stay was 62.0 AE 46.0 days.
Conservative management
All patients received antimicrobial therapy after sepsis was suspected. They were all also anticoagulated after the diagnosis of catheter related thrombosis. The blood and catheter cultures were positive in 31 (67.4%) and 25 (54.3%) patients, respectively. The most common pathogens were Staphylococcus aureus (n ¼ 15; 32.6%) and Candida species (n ¼ 8; 17.4%). Conservative management led to clinical improvement in 26 (56.5%) patients, but failed in 20 (43.5%). Thirteen (28.3%) of the patients who failed conservative management underwent surgical thrombectomy. The remaining seven did not: four (8.7%) died in hospital and three (6.5%) could not undergo surgery because of an unacceptable general condition. Thus, in total, 33 patients received conservative management without surgical thrombectomy. Of these, eight (24.2%) died in hospital and two (8.0%) died during the follow up period (59.0 AE 3.4 months) ( Table 2) .
Surgical thrombectomy
Thirteen (28.3%) patients were refractory to conservative management and underwent surgical thrombectomy. The intra-operative findings in most cases revealed intense perivascular inflammation that enveloped the vein containing the thrombus. The thrombus material was thick, organized, and densely adherent to the vein wall (Fig. 2) . The thrombus was removed completely in six of the 13 (46.2%) patients. In the remaining seven (53.8%) patients, small remnants of the partially organized clots remained at the proximal vein wall. There were no post-operative complications that related to the surgical procedure, except for one (7.7%) wound hematoma. The patency of the involved vein was re-established in 12 (92.3%) patients. Although only three of the 13 (23.1%) patients who underwent surgery had a positive tissue culture, clinical improvement was achieved in 11 (84.6%). Moreover the pyrexia of the five patients whose blood cultures were positive for Candida species promptly returned to normal after surgical thrombectomy. Of the 13 patients treated surgically, there were three (23.1%) in hospital deaths, and three of the 10 (30.0%) survivors died during the follow up period (43.0 AE 8.1 months) ( Table 2) .
DISCUSSION
Central venous catheters are subject to thrombosis and infection. The frequency of these complications depends on the duration of catheterization and various host factors. 5e11 The risk of infection varies with a number of factors, such as the type of device, the insertion site, and adherence to preventive measures. 7e9 It also appears that the risk of infection is not linear with the duration of catheterization but increases over time. 8 In addition, central venous catheter related infected thrombosis is known to increase the length of hospital stay, as well as hospital costs. 7e9 Although the vast majority of catheter related thromboses are occult and may not present clinically, it can be a serious infectious complication that leads to significant morbidity and, if left untreated, death. 1e12 Furthermore, as the pathogenesis of catheter related infections is complicated, the virulence of the pathogens is variable, and the host factors have not been well defined. Thus, there is a notable lack of compelling clinical data that helps the care team make a firm recommendation for an individual patient. 7 Long-term catheters may develop a fibrin sheath or tail at the distal catheter tip. Moreover, the daily infusion of hypertonic parenteral solutions may cause central venous thrombosis. Clots near to or on the catheter surface are prime sites for microbial seeding and eventual infection. 6 Patients receiving long-term parenteral nutrition may also have severe trauma and critical illnesses and/or have to undergo major surgery. All of these factors significantly affect immune function and increase the risk of developing infection. 6 In addition to focal thrombophlebitis, the infection can spread to other visceral organs, resulting in pneumonia, infective endocarditis, or metastatic seeding. 3,7e9 Staphylococcus aureus, coagulase-negative Staphylococci, and Candida species are the most common causes of catheter related bloodstream infection. 7e9 Central venous catheter related infected thrombosis can cause lethal complications such as persistent bacteremia, shock, and metastatic infection. 3 The diagnosis of septic thrombosis in immobilized and critically ill patients is difficult to establish by clinical examination, although extremity or facial edema that corresponds to the involved vein may develop. 1 However, the known risk factors for the development of the disease are total parenteral nutrition via a central venous catheter, prior surgery or trauma, multiple previous antibiotic therapies, prolonged venous catheterization, and many conditions that result in immunosuppression. Whenever a patient has any of these risk factors for catheter related infected thrombosis, there must be a very high level of suspicion. 3, 5 While ultrasonographic evaluation can help to detect the venous thrombosis, CT scanning is also of great benefit as it can also reveal the extent of the thrombosis and the presence of peri-venous fluid, soft tissue abscesses, or additional organ involvement. 1 In cases of suspected central venous catheter related infected thrombosis, treatment includes the prompt removal or change of the catheter, antibiotic therapy, anticoagulation therapy, and cultures of the blood and the tip of the catheter. However, anticoagulation is not mandatory for successful treatment, 1 and further study is needed to determine whether this therapy actually does prevent further thrombosis in the setting of catheter related infection. Nevertheless, in the absence of contraindications, it is recommended that anticoagulation be part of the conservative management of this disease. The good overall outcomes of this kind of management (especially when it is performed with modern, more effective antibiotic drugs) is the main reason why many authors regard antibiotic and anticoagulation therapy as an adequate treatment strategy for septic thrombophlebitis after intravenous catheter placement. 1 However, the substantial complication rate associated with this strategy has led several authors to recommend a surgical approach if the sepsis is refractory to this conservative treatment. 1, 10 The surgical management of septic thrombophlebitis consists of various treatment modalities. 1 Surgical thrombectomy can safely remove the source of embolization and the patency of the vein is re-established in many cases. 1 In addition, surgical thrombectomy may enhance the effectiveness of antibiotic therapy because it removes most of the infected material, leaving the infected vein wall in close contact with the antibiotic. 1 In most cases, the thrombus material is old and smaller remnants of the partially organized clots can remain on the vein wall. 1 Recent reports show that endovascular treatment may also be a useful addition in the management of catheter related infected thrombosis. 13e18 However, one report shows that thrombolysis alone or in conjunction with mechanical thrombectomy can trigger significant deterioration, presumably because it releases infected emboli into the systemic circulation. 13 Future studies with larger cohorts that examine the risks and benefits of endovascular treatment in catheter related septic thrombosis are warranted.
In the present study, 13 (28.3%) patients were refractory to conservative management but had a sufficiently good clinical condition to undergo surgical thrombectomy. After surgical thrombectomy, clinical improvement was achieved in 11 (84.6%). In particular, all five patients whose blood culture was positive for Candida species promptly defervesced after surgical thrombectomy. It has been well documented that fungemia is associated with total parenteral nutrition, antibiotic use, prolonged venous catheterization, and many conditions resulting in immunosuppression. 3, 5 Unlike bacterial thrombophlebitis, fungal thrombophlebitis is unimpressive in its appearance and thus is often not discovered until it is specifically investigated. Unfortunately, this usually only occurs after fungemia, shock, or organ failure is recognized. 19, 20 Surgical patients, especially those with intra-abdominal infection, who are critically ill while being treated with long-term antimicrobial therapy should be suspected of fungal infection. 3 The catheter should be removed in cases of central venous catheter related septic thrombosis due to Candida species. 7 Echinocandins are the preferred treatment in catheter related fungemia. For patients who cannot tolerate echinocandins, lipid formulations of amphotericin B are an alternative. Fluconazole can be considered if patients are not critically ill and if they have not had recent exposure to azoles. 7e9 Treatment for 14 days after the first negative blood culture is sufficient in uncomplicated fungemia without persistent fungemia or metastatic complications. 7e9 Several limitations should be noted. This study has a retrospective design and the decision of whether or not and when to perform a surgical thrombectomy was made by the surgeon, based on the expected level of the efficacy of conservative management and the patient's general condition. Furthermore, the number of patients that underwent surgical thrombectomy was relatively small. Hence, in the patients who received surgical treatment, clinical improvement in some of these patients may only have represented the natural course of the disease. Future studies on larger cohorts are warranted.
The small sample size in the present study means that the importance of surgical thrombectomy in the treatment of central venous catheter related infected thrombosis cannot yet be definitively determined. Without doubt, conservative management is the first therapy of choice. However, the authors believe that surgical thrombectomy can be beneficial and life saving in selected patients who fail conservative management. This approach may be controversial, but it should be emphasized that it does not compete with conservative management: rather, it is a supplemental treatment modality whose application depends on the severity of the disease and its efficacy relative to conservative management.
